Trump's latest tariff blitz sent shockwaves through global markets, with volatility surging. The Fed held rates steady at 4.5%, creating uncertainty about September cuts while traders scramble for direction. Global conflicts are fragmenting supply chains and fueling energy price spikes.
But here's what most traders miss: Like autumn leaves falling predictably each year, certain stocks follow seasonal patterns that smart money has exploited for decades. While others panic, you can position yourself for the harvest.
Some opportunities literally fall into your lap – this is one of them. While tariff chaos creates the noise, these seasonal signals cut through to profits.
Applied Materials (AMAT) reported earnings of $2.48 per share on revenue of $7.30 billion for the fiscal third quarter ended July 2025. The consensus earnings estimate was $2.34 per share on revenue of $7.20 billion. The Earnings Whisper number was $2.40 per share. The company beat expectations by 3.33% while revenue grew 7.73% on a year-over-year basis.
The company said it expects fourth quarter earnings of $1.91 to $2.31 per share on revenue of $6.20 billion to $7.20 billion. The current consensus earnings estimate is $2.36 per share on revenue of $7.32 billion for the quarter ending October 31, 2025.
Applied Materials Inc provides manufacturing equipment, services and software to the global semiconductor, flat panel display, solar photovoltaic and related industries.
Positive Guidance
Newton Golf Raises Guidance
Newton Golf Company (NWTG) said it expects 2025 revenue of $7.0 million to $7.5 million. The company's previous guidance was $6.5 million to $7.0 million and the current consensus revenue estimate is $6.7 million for the year ending December 31, 2025.
Newton Golf harnesses the power of physics to revolutionize golf equipment design.
Lifeward (LFWD) said it expects 2025 revenue of $24.0 million to $26.0 million. The company's previous guidance was revenue of $28.0 million to $30.0 million and the current consensus revenue estimate is $29.02 million for the year ending December 31, 2025.
Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community.
Virginia Stock-Picking Millionaire Says It’s Not About Diversification! One single stock under $5- that trades under a secret name- could help you build your retirement. His details are here.
Positive Surprise
Abeona Therapeutics Beat Consensus Estimates
Abeona Therapeutics (ABEO) reported earnings of $1.71 per share on revenue of $0.40 million for the second quarter ended June 2025. The consensus estimate was a loss of $0.39 per share on revenue of $7.05 million. The company beat consensus estimates by 538.46%.
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing cell and gene therapies for serious diseases.
Evolv Technology (EVLV) reported a loss of $0.25 per share on revenue of $32.54 million for the second quarter ended June 2025. The consensus estimate was a loss of $0.09 per share on revenue of $29.25 million. The Earnings Whisper number was a loss of $0.06 per share. The company missed expectations by 316.67% while revenue grew 27.42% on a year-over-year basis.
The company said it expects 2025 revenue of $132.0 million to $135.0 million. The company's previous guidance was revenue of $125.0 million to $130.0 million and the current consensus revenue estimate is $126.22 million for the year ending December 31, 2025.
Evolv Technology is a leader in weapons detection for security screening, securing the world’s most iconic venues and companies.
Flowers Foods is Expected to Beat Estimates
Flowers Foods (FLO) is confirmed to report earnings on Friday, August 15, 2025 at approximately 7:00 AM ET. The consensus earnings estimate is $0.29 per share on revenue of $1.27 billion, respresenting 3.7% year-over-year revenue growth, and the Earnings Whisper ® number is $0.30 per share. Investors are 46.0% bearish going into the company's earnings release. Option traders are pricing in a 10.4% move on earnings and the stock has averaged a 2.5% move in recent quarters.